PURPOSE: Human alveolar (AE) and cystic echinococcosis (CE) caused by the metacestode stages of Echinococcus multilocularis and E. granulosus, respectively, lack pathognomonic clinical signs. Diagnosis therefore relies on the results of imaging and serological studies. The primary goal of this study was to evaluate the efficacy of several easy-to-produce crude or partially purified E. granulosus and E. multilocularis metacestode-derived antigens as tools for the serological diagnosis and differential diagnosis of patients suspicious for AE or CE. METHODS: The sera of 51 treatment-naïve AE and 32 CE patients, 98 Swiss blood donors and 38 patients who were initially suspicious for echinococcosis but suffering from various other liver diseases (e.g., liver neoplasia, etc.) were analysed. RESULTS: According to the results of enzyme-linked immunosorbent assays (ELISA), metacestode-derived antigens of E. granulosus had sensitivities varying from 81 to 97% and >99.9% for the diagnosis of CE and AE, respectively. Antigens derived from E. multilocularis metacestodes had sensitivities ranging from 84 to 91% and >99.9% for the diagnosis of CE and AE, respectively. Specificities ranged from 92 to >99.9%. Post-test probabilities for the differential diagnosis of AE from liver neoplasias, CE from cystic liver lesions, and screening for AE in Switzerland were around 95, 86 and 2.2%, respectively. Cross-reactions with antibodies in sera of patients with other parasitic affections (fasciolosis, schistosomosis, amebosis, cysticercosis, and filarioses) did occur at variable frequencies, but could be eliminated through the use of confirmatory testing. CONCLUSIONS: Different metacestode-derived antigens of E. granulosus and E. multilocularis are valuable, widely accessible, and cost-efficient tools for the serological diagnosis of echinococcosis. However, confirmatory testing is necessary, due to the lack of species specificity and the occurrence of cross-reactions to other helminthic diseases.
PURPOSE:Human alveolar (AE) and cystic echinococcosis (CE) caused by the metacestode stages of Echinococcus multilocularis and E. granulosus, respectively, lack pathognomonic clinical signs. Diagnosis therefore relies on the results of imaging and serological studies. The primary goal of this study was to evaluate the efficacy of several easy-to-produce crude or partially purified E. granulosus and E. multilocularis metacestode-derived antigens as tools for the serological diagnosis and differential diagnosis of patients suspicious for AE or CE. METHODS: The sera of 51 treatment-naïve AE and 32 CE patients, 98 Swiss blood donors and 38 patients who were initially suspicious for echinococcosis but suffering from various other liver diseases (e.g., liver neoplasia, etc.) were analysed. RESULTS: According to the results of enzyme-linked immunosorbent assays (ELISA), metacestode-derived antigens of E. granulosus had sensitivities varying from 81 to 97% and >99.9% for the diagnosis of CE and AE, respectively. Antigens derived from E. multilocularis metacestodes had sensitivities ranging from 84 to 91% and >99.9% for the diagnosis of CE and AE, respectively. Specificities ranged from 92 to >99.9%. Post-test probabilities for the differential diagnosis of AE from liver neoplasias, CE from cystic liver lesions, and screening for AE in Switzerland were around 95, 86 and 2.2%, respectively. Cross-reactions with antibodies in sera of patients with other parasitic affections (fasciolosis, schistosomosis, amebosis, cysticercosis, and filarioses) did occur at variable frequencies, but could be eliminated through the use of confirmatory testing. CONCLUSIONS: Different metacestode-derived antigens of E. granulosus and E. multilocularis are valuable, widely accessible, and cost-efficient tools for the serological diagnosis of echinococcosis. However, confirmatory testing is necessary, due to the lack of species specificity and the occurrence of cross-reactions to other helminthic diseases.
Authors: Gihan M Tawfeek; Hala S Elwakil; Laila El-Hoseiny; Hala S Thabet; Rania M Sarhan; Nabil S Awad; Wagida A Anwar Journal: Parasitol Res Date: 2010-10-05 Impact factor: 2.289
Authors: Alexander Schweiger; Rudolf W Ammann; Daniel Candinas; Pierre-Alain Clavien; Johannes Eckert; Bruno Gottstein; Nerman Halkic; Beat Muellhaupt; Bettina Mareike Prinz; Juerg Reichen; Philip E Tarr; Paul R Torgerson; Peter Deplazes Journal: Emerg Infect Dis Date: 2007-06 Impact factor: 6.883
Authors: Letizia Cattaneo; Tommaso Manciulli; Carmen-Michaela Cretu; Maria Teresa Giordani; Andrea Angheben; Alessandro Bartoloni; Lorenzo Zammarchi; Filippo Bartalesi; Joachim Richter; Peter Chiodini; Gauri Godbole; Thomas Junghanss; Marija Stojkovic; Luigi Sammarchi; Roberto Dore; Alessandro Vercelli; Francesco Benazzo; Fabrizio Cuzzocrea; Francesca Tamarozzi; Enrico Brunetti Journal: Am J Trop Med Hyg Date: 2019-03 Impact factor: 2.345
Authors: Philipp A Kronenberg; Ansgar Deibel; Bruno Gottstein; Felix Grimm; Beat Müllhaupt; Cordula Meyer Zu Schwabedissen; Sezdbek Aitbaev; Rakhatbek A Omorov; Kubanychbek K Abdykerimov; Gulnara Minbaeva; Jumagul Usubalieva; Mar Siles-Lucas; Paola Pepe; Laura Rinaldi; Markus Spiliotis; Junhua Wang; Norbert Müller; Paul R Torgerson; Peter Deplazes Journal: Pathogens Date: 2022-04-27
Authors: Thomas F E Barth; Tobias S Herrmann; Dennis Tappe; Lorenz Stark; Beate Grüner; Klaus Buttenschoen; Andreas Hillenbrand; Markus Juchems; Doris Henne-Bruns; Petra Kern; Hanns M Seitz; Peter Möller; Robert L Rausch; Peter Kern; Peter Deplazes Journal: PLoS Negl Trop Dis Date: 2012-10-25
Authors: Rudolf W Ammann; Katrin D M Stumpe; Felix Grimm; Peter Deplazes; Sabine Huber; Kaja Bertogg; Dorothee R Fischer; Beat Müllhaupt Journal: PLoS Negl Trop Dis Date: 2015-09-21
Authors: Raúl Manzano-Román; Carlos Sánchez-Ovejero; Ana Hernández-González; Adriano Casulli; Mar Siles-Lucas Journal: Biomed Res Int Date: 2015-10-04 Impact factor: 3.411
Authors: Linda Petrone; Werner C Albrich; Francesca Tamarozzi; Manuel Frischknecht; Maria Angeles Gomez-Morales; Antonella Teggi; Matthias Hoffmann; Delia Goletti Journal: Parasite Immunol Date: 2020-02-07 Impact factor: 2.280
Authors: Bakhadyr Bebezov; Nurlan Mamashev; Tilek Umetaliev; Iskender Ziadinov; Philip S Craig; Deborah E Joekel; Peter Deplazes; Felix Grimm; Paul R Torgerson Journal: Emerg Infect Dis Date: 2018-06 Impact factor: 6.883